Insider · CIK 0001346064
Brett Sandercock
cfoofficer
Files at RMD (RESMED INC). First filing Nov 12, 2024, latest Jun 3, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 5
$0 bought, $1.8M sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
RMD: RESMED INC
RMDOct 9, 2026 · close 230.05
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 30Weak | RESMED INC | $244k 1,000 shares | -1% | +20% from low-5% from high | |
| 40Moderate | RESMED INC | $891k 3,644 shares | -4% | +20% from low-4% from high | |
| 29Weak | RESMED INC | $216k 1,000 shares | -1% | 0% from low-20% from high | |
| 30Weak | RESMED INC | $244k 1,000 shares | -1% | - | |
| 30Weak | RESMED INC | $249k 1,000 shares | -1% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 2, 2025 | RMD RESMED INC | SOpen-market sale ResMed Common Stock10b5-1 | -1,000 | $243.78 | $244k | 85,283 | Jun 3, 2025 |
| May 22, 2025 | RMD RESMED INC | SOpen-market sale ResMed Common Stock10b5-1 | -3,644 | $244.59 | $891k | 86,283 | May 27, 2025 |
| Apr 8, 2025 | RMD RESMED INC | SOpen-market sale ResMed Common Stock10b5-1 | -1,000 | $215.58 | $216k | 89,864 | Apr 10, 2025 |
| Dec 9, 2024 | RMD RESMED INC | SOpen-market sale ResMed Common Stock10b5-1 | -1,000 | $244.23 | $244k | 93,864 | Dec 11, 2024 |
| Nov 8, 2024 | RMD RESMED INC | SOpen-market sale ResMed Common Stock10b5-1 | -1,000 | $249.00 | $249k | 94,864 | Nov 12, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.